Ozempic Users Who Lost 15% Weight Cut Disease Risk by 69%

Losing significant weight on popular medications like Ozempic and Mounjaro isn't just about the number on the scale. It's about dramatically improving your health in ways that could add years to your life.

A major study tracking nearly 90,000 patients found that people who lost at least 15% of their body weight on GLP-1 medications saw remarkable health improvements. Their risk of obstructive sleep apnea dropped by 69%, chronic kidney disease fell by 30%, and osteoarthritis decreased by 37%.

Researchers from the University of Liverpool analyzed real-world data from patients who started taking semaglutide (Ozempic or Wegovy), tirzepatide (Mounjaro), or liraglutide (Saxenda) between 2021 and 2024. The average patient was 57 years old with a BMI of 34.7, and about 61% had type 2 diabetes.

The findings presented at the European Congress on Obesity revealed something important: more weight loss meant better health outcomes. Even people who reduced their BMI by just 5% to 10% saw benefits, though they weren't as dramatic as those who lost more.

Here's what makes this study particularly meaningful. About half of all patients stopped taking their medication within a year, yet researchers still measured their outcomes based on the weight they lost during treatment. This reflects real life, where not everyone stays on medication long-term.

The research also uncovered a concerning flip side. Patients who actually gained weight after starting treatment faced higher health risks. Their sleep apnea risk increased by 22% and heart failure risk jumped by 69% compared to those who lost a small amount of weight.

The study followed patients for an average of 11 months after their first year of treatment. During this time, researchers tracked new diagnoses of osteoarthritis, chronic kidney disease, obstructive sleep apnea, and heart failure.

The Bright Side

This research offers hope for millions of people struggling with obesity-related health conditions. It shows that these medications can deliver genuine, measurable health improvements beyond just weight loss. The key is actually losing weight and ideally maintaining that loss.

The findings also suggest that even modest weight loss makes a difference. You don't have to reach the highest tier of weight loss to see health benefits, though greater losses do appear to bring greater rewards.

What's particularly encouraging is how quickly these benefits appeared. Within just months of losing weight, patients showed reduced rates of serious health conditions that can significantly impact quality of life.

These results give doctors and patients clearer guidance on what to aim for when using these medications and underscore why maintaining weight loss matters so much for long-term health.